BAY-179

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBAY-179
Drug Alias NameBAY-179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH-ubiquinone oxidoreductase chain 1 gene transference
TargetsNADH-ubiquinone oxidoreductase chain 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A